Etanercept-associated injection-site reactions

被引：15

作者：

Murphy, FT ^{[1
]}

Enzenauer, RJ ^{[1
]}

Battafarano, DF ^{[1
]}

David-Bajar, K ^{[1
]}

机构：

[1] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA

来源：

ARCHIVES OF DERMATOLOGY | 2000年 / 136卷 / 04期

关键词：

D O I：

10.1001/archderm.136.4.556

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：556 / 557

页数：2

共 5 条

[1] Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial [J].

Moreland, LW ;

Schiff, MH ;

Baumgartner, SW ;

Tindall, EA ;

Fleischmann, RM ;

Bulpitt, KJ ;

Weaver, AL ;

Keystone, EC ;

Furst, DE ;

Mease, PJ ;

Ruderman, EM ;

Horwitz, DA ;

Arkfeld, DG ;

Garrison, L ;

Burge, DJ ;

Blosch, CM ;

Lange, MLM ;

McDonnell, ND ;

Weinblatt, ME .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :478-+

[2] Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein [J].

Moreland, LW ;

Baumgartner, SW ;

Schiff, MH ;

Tindall, EA ;

Fleischmann, RM ;

Weaver, AL ;

Ettlinger, RE ;

Cohen, S ;

Koopman, WJ ;

Mohler, K ;

Widmer, MB ;

Blosch, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :141-147

[3]

Schuna A A, 1998, J Am Pharm Assoc (Wash), V38, P728

[4]

WEINBLATT M, 1997, ARTHRITIS RHEUM S, V40, P126

[5] A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate [J].

Weinblatt, ME ;

Kremer, JM ;

Bankhurst, AD ;

Bulpitt, KJ ;

Fleischmann, RM ;

Fox, RI ;

Jackson, CG ;

Lange, M ;

Burge, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :253-259

← 1 →